Bristol Myers Squibb
About Bristol Myers Squibb
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Debt T: - FT: Debt |
A: 5000000000 MR: - FA: €5 billion FAN: 5000000000 |
D: 2025-11-10 FD: 2025-11-10 |
5 investors |
| 2 |
RT: Debt T: - FT: Debt |
A: 4500000000 MR: - FA: $4.5 billion FAN: 4500000000 |
D: 2023-10-30 FD: 2023-10-30 |
4 investors |
Growth Metrics
Team & Leadership
Ralston Barnes
Scientific Director of Transgenic Discovery, Discovery Biotherapeutics Bristol Myers Squibb
Neil Bence
Vice President, Head of Oncology Discovery
Edgar Charles
Vice President, Global Program Lead, Immunology, Drug Development
Roland Chen
Senior Vice President, Drug Development, Cardiovascular & Immunology Medicines
Elizabeth (Liz) Colston
Head of Immunology Clinical Development
Justine Dell'Aringa
Senior Director, Translational Research, Cancer Immunology and Cell Therapy Thematic Research Center
Recent News
Bristol Myers Squibb Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- bms.com
- Industries
- Biopharmaceutical
- Company Size
- ~460 employees (est.)
- Locations
-
Big Island, Waikoloa Village, HI
Not specified
Exton, PA, USA +8 more
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro